Abstract : Pregnant mice fed methylmercury alone or methylmercury and selenite simultaneously for 30 precoital days and thereafter up to Day 18 of gestation were examined for organ and tissue mercury concentrations and embryonic and fetal death. Coadministration of selenite increased maternal liver mercury concentrations and decreased maternal kidney mercury concentrations.
INTRODUCTION
Experimental details concerning the feeding experiment were described in a previous report3), briefly, female IVCS mice were fed methylmercury and selenite for 30 precoital days and thereafter up to Day 18 of gestation, at which time the maternal mice were anesthetized with ether and the uterus was exposed to examine the number of total implants consisting of surviving fetuses, dead fetuses, dead embryos, resorptions and implantation sites. The surviving fetuses were examined for gross abnormalities.
From the groups fed (1) methylmercury at the dose level of 15.9 nmol/g feed, (2) methylmercury, 15.9 nmol/g and selenite, 11.4 nmol/m/ drinking water, (3) methylmercury, 31.9 nmol/g, or (4) methylmercury, 31.9 nmol/g and selenite, 11.4 nmol/ml, three or four mice each were randomly selected. Organs and tissues were collected for mercury measurement and stored in a freezer until analyzed. Mercury was measured by the method of Magos4).
In the statistical analysis, correlational analysis and the T2-test by Hotelling5) were applied to the paired data of the death rate of embryos and fetuses and the organ (or tissue) mercury concentration. Prior to the statistical analysis, angular transformation of the rate and logarithmic transformation of the mercury concentation were conducted.
RESULTS
Death records of mouse embryos and fetuses are shown in Table 1 . Gross abnormalities (hare lip or cleft palate) were noted in only two mice.
Total mercury concentrations in organs and tissues were compared by doselevels of methylmercury and coadministration of selenite, the latter of which produced increased maternal liver mercury concentrations and decreased maternal kidney mercury concentrations (Table 2) . Except for these two organs, no difference was produced by coadministered selenite.
Significant correlation coefficients between the organ mercury concentration and the early death rate of embryos (number of implantation sites and resorptions per total number of implants) were observed for the amniotic fluid and fetal brain (Table 3 ). The total death rate (number of total embryonic and fetal deaths per total number of implants) was correlated with the organ mercury AND FETAL DEATH RATE 21 concentration for most of the organs and tissues except for the placenta and fetal brain. When the animals were divided into two groups, i.e., the group given methylmercury alone and that coadministered selenite, the correlation coefficients calculated for the respective groups became greater in the former group for all the organs and tissues except the fetal brain and smaller in the latter group, as compared to the levels when the two groups were combined (Table 3 ). The correlation coefficients for the blood and amniotic fluid showed, in all cases, the largest values.
A significant difference between the methylmercury alone and the selenite coadministered groups in terms of the two dimensional distribution of mercury concentrations vs. total death rates was observed for the maternal liver, maternal blood and amniotic fluid by the T2-test of Hotelling (Table 3 ). Figure 1 shows this distribution.
If we consider that the organ (or tissue) mercury concentration means the dose and the total death rate, i.e., the response, this figure will reveal dose-response functions.
From paucity of data, we cannot conclusively state that the modification is due to selenite, but, in the maternal blood or amniotic fluid, not in the maternal liver, a linearity remains in both the methylmercury alone and selenite coadministered groups in the function. Apparently, there is an upward shift of the function by selenite coadministration in both cases.
DISCUSSION
Total mercury concentrations in organs and tissues were well correlated with total death rates of embryos and fetuses, but not with early death rates. The correlation was greater in the methylmercury alone than in the selenite coad- ministered group for most organs and tissues; the blood and fetal brain were exceptions. Absence of significant correlations, or small values even when significant, between the early death rate and the mercury concentration may be explained by a gap between the time when early deaths occurred and that when the organs were collected. Because the surviving fetuses were only subjcted to mercury analysis, the mercury value obtained did not represent the level when it induced embryonic fatality.
From the present results, i.e., large coefficients of some 0.9 between the total death rate and the mercury concentration, two tissues, maternal blood and amniotic fluid, seem to be useful as index media for evaluating the critical organ concentration, even when sampling is conducted in the late period of gestation, as in the present experiments.
An apparent upward shift of dose-response functions in both the blood and amniotic fluid by selenite coadministration suggests an additive or synergistic effect of selenite. Injection of pregnant mice with selenite solution induces fetal growth retardation, absortion or maternal death according to the dosages) . Selenite feeding in the present study might have caused subtle changes that resulted in increased embryonic and fetal deaths, even though the feeding of selenite alone merely produced non-significant fetal growth retardation in a previous study3). In any case, the precise mechanism of methylmercury-selenite interaction producing this phenomenon needs to be further studied. 
